Friday, October 13, 2023 7:10:26 AM
So logic dictates they would have chosen a date associated with a fixed once-a-month deadline, otherwise why not give themselves to the deadline after that, and if they already selected and provided a future date of anticipated submission to the MHRA before the August 29 PR, we can somewhat safely assume they selected September 25. Which would mean we’re waiting on MHRA to accept/validate, and normally that should have been completed by October 9, and four business days from October 9 is today, assuming MHRA got it done back on October 9. So the premise goes anyway.
Maybe. But why wait the extra four business days, unless they didn’t wait and MHRA is simply a little slow, because, as Marty said, MHRA is short staffed again. Or, maybe, they did wait the four days to tell us the clock started at zero four days ago, making the next chm dates of December 21/22 a little closer to two months from next pr.
Or, again, maybe MHRA is just slow, and they need a bit more time.
I dunno.
Or perhaps they didn’t select September 25 as their anticipated dossier submission date,
and gave a later date so the MHRA would have more time to validate before the next monthly chm schedule deadline for dossiers.
Maybe it all comes down to whether they would like approval before or after the end of the year.
Could they handle an approval in this calendar year?
Maybe. But why wait the extra four business days, unless they didn’t wait and MHRA is simply a little slow, because, as Marty said, MHRA is short staffed again. Or, maybe, they did wait the four days to tell us the clock started at zero four days ago, making the next chm dates of December 21/22 a little closer to two months from next pr.
Or, again, maybe MHRA is just slow, and they need a bit more time.
I dunno.
Or perhaps they didn’t select September 25 as their anticipated dossier submission date,
and gave a later date so the MHRA would have more time to validate before the next monthly chm schedule deadline for dossiers.
Maybe it all comes down to whether they would like approval before or after the end of the year.
Could they handle an approval in this calendar year?
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
